Merit Medical Systems (MMSI) Tops Q2 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Merit Medical Systems (MMSI) Announces Proposed 3.5M Share Common Offering
July 24, 2018 4:14 PM EDTMerit Medical Systems, Inc. (NASDAQ: MMSI) today announced that it has commenced an underwritten public offering of shares of its common stock. Merit expects to offer 3,500,000 shares of common stock and also plans to grant the underwriters participating in the offering a 30-day... More
Merit Medical Systems, Inc. (MMSI) PT Raised to $61 at Barrington Research
July 24, 2018 8:30 AM EDTBarrington Research raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $61.00 (from $50.00) while maintaining a Outperform rating.
... MoreMerit Medical Systems, Inc. (MMSI) PT Raised to $70 at Canaccord Genuity
July 24, 2018 7:08 AM EDTCanaccord Genuity raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $70.00 (from $60.00) while maintaining a Buy rating.
... MoreMerit Medical Systems, Inc. (MMSI) PT Raised to $67 at Needham & Company
July 24, 2018 6:31 AM EDTNeedham & Company raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $67.00 (from $54.00) while maintaining a Buy rating.
Analsyt Mike Matson commented, "MMSI's 2Q18 revenue and EPS beat consensus. Management raised its 2018 revenue and EPS guidance but lowered its 2018 gross margin... More
